CV THERAPEUTICS INC (CVTX) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 294 transactions totaling $14.1M, demonstrating a bearish sentiment with -$14.1M in net insider flow. The most recent transaction on Apr 9, 2009 involved a transaction of 20,278 shares valued at $404.3K.
No significant insider buying has been recorded for CVTX in the recent period.
No significant insider selling has been recorded for CVTX in the recent period.
Based on recent SEC filings, insider sentiment for CVTX is bearish with an Insider Alignment Score of 0/100 and a net flow of -$14.1M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at CV THERAPEUTICS INC (CVTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading CVTX stock, having executed 294 transactions in the past 90 days. The most active insider is Louis G. Lange (Executive), who has made 78 transactions totaling $21.6M.
Get notified when executives and directors at CVTX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Apr 9, 2009 | G. Lange Louis | Executive | Payment | 20,278 | $19.94 | $404.3K | |
| Apr 9, 2009 | K. Spiegelman Daniel | Executive | Payment | 5,950 | $19.94 | $118.6K | |
| Apr 8, 2009 | J. Stuart Lewis | Executive | Payment | 7,988 | $19.94 | $159.3K | |
| Apr 8, 2009 | J. Stuart Lewis | Executive | Option Exercise | 98,958 | $10.45 | $1.0M | Large |
| Apr 8, 2009 | J. Stuart Lewis | Executive | Payment | 69,569 | $19.94 | $1.4M | Large |
| Apr 8, 2009 | J. Stuart Lewis | Executive | Payment | 6,457 | $19.94 | $128.8K | |
| Apr 8, 2009 | J. Stuart Lewis | Executive | Option Exercise | 8,100 | $13.33 | $108.0K | |
| Apr 8, 2009 | J. Stuart Lewis | Executive | Option Exercise | 10,000 | $13.38 | $133.8K | |
| Apr 7, 2009 | E. Shenk Thomas | Executive | Option Exercise | 7,500 | $15.60 | $117.0K | |
| Apr 7, 2009 | E. Shenk Thomas | Executive | Payment | 7,500 | $19.94 | $149.6K | |
| Apr 7, 2009 | E. Shenk Thomas | Executive | Option Exercise | 7,500 | $19.91 | $149.3K | |
| Apr 7, 2009 | E. Shenk Thomas | Executive | Payment | 8,394 | $19.94 | $167.4K | |
| Apr 7, 2009 | E. Shenk Thomas | Executive | Option Exercise | 12,500 | $8.74 | $109.3K | |
| Apr 7, 2009 | E. Shenk Thomas | Executive | Payment | 5,428 | $19.94 | $108.2K | |
| Apr 7, 2009 | E. Shenk Thomas | Executive | Option Exercise | 7,500 | $10.45 | $78.4K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Exercise(M) | 118 | $22.3M | 43.1% |
Sale(S) | 37 | $14.1M | 27.2% |
Payment(F) | 114 | $14.0M | 27.1% |
Award(A) | 17 | $1.3M | 2.6% |
Gift(G) | 5 | $37.7K | 0.1% |
Small Acquisition(L) | 3 | $768 | 0.0% |
Insider selling pressure at CV THERAPEUTICS INC has increased, with 12 insiders executing 294 transactions across all time. Total sales of $14.1M significantly outpace purchases of $0, resulting in a net outflow of $14.1M. This selling activity appears largely discretionary, which may warrant closer attention from investors.